- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Breast cancer
- Meeting Date: December 2022
- Public Summary Document (PSD) December 2022 July 2023 PBAC Meetings - (PDF 512KB)
- Public Summary Document (PSD) December 2022 July 2023 PBAC Meetings - (Word 77KB)
Zoledronic acid – December 2022
Zoledronic acid: Injection concentrate for I.V. infusion 4 mg (as monohydrate) in 5 mL; APO-Zoledronic Acid® - December 2022 - July 2023 PBAC meetings
Last updated
21 April 2023